DBV Technologies SA (FRA:DBV)
€ 0.65 0.04 (6.56%) Market Cap: 64.46 Mil Enterprise Value: 28.17 Mil PE Ratio: 0 PB Ratio: 1.32 GF Score: 36/100

Dbv Technologies SA at JMP Securities Life Sciences Conference Transcript

May 15, 2023 / 01:00PM GMT
Release Date Price: €3.25 (-12.37%)
John Walden
JMP Securities - Analyst

Welcome everyone to day-one of the JMP Life Sciences Conference. My name is John Walden, senior analyst here. We're pleased to kick off the day and the conference this morning with DBV Technologies and CEO, Daniel Tassé.

Daniel TassÃ;DBV Technologies S.A.;CEO

©,-

Good morning, all.

John Walden
JMP Securities - Analyst

Thank you for coming. And I think you people have been following the story for a little bit of time. They know you're working on peanut allergy. But we have a lot of new news coming in the past couple of weeks. Some developments I want to get into. But maybe can you give a little bit of a history of the company? Because it's been some twists and turns. And then maybe that gets at the stage, we're talking about the technology and then we can get into the news in the past couple of weeks.

Daniel TassÃ;DBV Technologies S.A.;CEO

©,-

I'll be happy to do so. So we're an immunology

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot